BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2014
View Archived Issues
Novel FabI inhibitors with promising activity against staphylococcal infections
Read More
Cleave Biosciences initiates phase I trial of CB-5083 in patients with solid tumors
Read More
Arisaph Pharmaceuticals initiates phase II study of ARI-3037-MO in hypertriglyceridemia
Read More
Uncovering de novo mutations that underscore epileptic encephalopathies
Read More
FDA grants Vivolux clearance to conduct phase I/II trial of VLX-1570
Read More
Updated phase I results for MSC-2156119J in advanced solid tumors
Read More
Deciphera Pharmaceuticals patents novel agents for cancer and other disorders
Read More
Novel pyrrolotriazines disclosed by Bristol-Myers Squibb for arrhythmia
Read More
Aurigene Discovery Technologies designs new NAmPRTase inhibitors
Read More
Takeda Pharmaceutical divulges novel ROR-gamma antagonists
Read More
Scientists at Roche synthesize novel autotaxin inhibitors
Read More
FDA approves Uceris rectal foam for induction of remission of distal ulcerative colitis
Read More
MedImmune in-licenses Shionogi's ACS biologic research program
Read More
PET imaging of Abeta plaques using a novel 89Zr-labeled MAb
Read More
Striverdi Respimat inhalation spray now available in the U.S.
Read More
E-6005 shows efficacy and safety in early clinical studies in patients with atopic dermatitis
Read More
Amgen reports topline results from phase III study of adalimumab biosimilar in psoriasis
Read More
Teva Pharmaceutical begins rolling NDA for CEP-33237
Read More
Ruthigen begins phase I/II trial of RUT-5860
Read More
Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy
Read More
Nabriva Therapeutics granted FDA QIDP and fast track status for lefamulin
Read More
Bristol-Myers Squibb to begin a phase I/II study of BMS-986012 in small cell lung cancer
Read More
FDA grants priority review to Lucentis submission for diabetic retinopathy
Read More
RedoxTherapies licenses Vernalis' vipadenant for immuno-oncology applications
Read More
Regen BioPharma files IND application for autologous dendritic cell therapy for breast cancer
Read More